Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19
- 17 July 2020
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 127 (3), 400-401
- https://doi.org/10.1161/circresaha.120.317173
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- DOACs and “newer” hemophilia therapies in COVID‐19: ReplyJournal of Thrombosis and Haemostasis, 2022
- Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidancePediatria i Medycyna Rodzinna, 2020
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Plasma Albumin and Incident Cardiovascular Disease Results From the CGPS and an Updated Meta-AnalysisArteriosclerosis, Thrombosis, and Vascular Biology, 2020
- Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in CirrhosisHepatology Communications, 2019
- Heparin like activity of albuminThrombosis Research, 1979